Gastro-Entero-Pancreatic | Open Access Journals

Journal of Genetics and Genomes

ISSN: 2684-4567

Open Access


Neuroendocrine tumors (NETs) are heterogeneous malignancies emerging from the diffuse neuroendocrine framework. They every now and again begin in the gastroenteropancreatic (GEP) tract and the bronchopulmonary tree, and their rate has consistently expanded over the most recent 3 decades. Key biologic and genomic contrasts underlie the clinical heterogeneity of NETs, and particular atomic highlights describe NETs of various evaluations and distinctive essential locales. Despite the fact that medical procedure remains the foundation of treatment for limited tumors, fundamental treatment choices for patients with metastatic NETs have extended impressively. Somatostatin analogs have shown both antisecretory and antitumor viability. Peptide receptor radionuclide treatment with lutetium-177 dotatate (177 Lu-DOTATATE) has been endorsed for cutting edge GEP-NETs

High Impact List of Articles
Conference Proceedings

Relevant Topics in Genetics & Molecular Biology

arrow_upward arrow_upward